By Curtis Williams and Scott DiSavino HOUSTON/NEW YORK (Reuters) – U.S. liquefied natural gas exports this year will rise about 2%, analysts estimate, the smallest annual increase since 2016 when the first big U.S. LNG export plant opened, launching a boom that drove the country’s producers to the top of world gas exporters. Slower gains …
US LNG exports to rise at smallest pace since 2016 Read More »
By Michael Erman and Leroy Leo (Reuters) -Merck & Co said on Thursday that weak sales of Gardasil in China are likely to carry over into 2025 as the vaccine’s distributor there reduces inventories amid low demand, and the U.S. drugmaker’s shares fell 3%. Gardasil, which prevents cancers caused by the human papillomavirus, has been …
Merck sees Gardasil China woes carrying into 2025 Read More »
By David Shepardson (Reuters) -Ford Motor will halt production of its F-150 Lightning electric vehicle pickup trucks for six weeks from Nov. 18 to Jan. 6, the Dearborn automaker said on Thursday. Ford’s U.S. plants are closed for a holiday week in December. “We continue to adjust production for an optimal mix of sales growth …
Ford to halt production of F-150 Lightning EV pickup trucks for six weeks Read More »
By Michael Erman (Reuters) -Bristol Myers Squibb reported a higher-than-expected third-quarter profit on Thursday, citing strong sales of established drugs like blood thinner Eliquis and cancer treatment Revlimid as well as newer products such as heart medicine Camzyos and cancer cell therapy Breyanzi. Shares were up 4.2% after earlier climbing to $56.20, their highest level …
Bristol Myers earnings beat expectations, driven by sales of older drugs Read More »
By Christy Santhosh (Reuters) – U.S. drugmaker Regeneron Pharmaceuticals on Thursday reported weaker-than-expected quarterly sales of the higher dose version of its blockbuster eye disease drug Eylea, sending its shares down 9%. That overshadowed the company surpassing Wall Street estimates for third-quarter profit and revenue.Regeneron has been looking to upgrade patients who use Eylea to …
Regeneron shares drop as higher-dose Eylea drug misses sales estimates Read More »
By Sriparna Roy (Reuters) -Cigna projected 2025 profit growth of at least 10% on Thursday, after posting quarterly results that beat Wall Street expectations, driven by strong demand for its specialty drugs and new clients for its pharmacy benefit management unit. Shares of the U.S. health insurer were up nearly 3%. The company said it …
Cigna forecasts 2025 profit growth of at least 10% after quarterly beat Read More »
(Amends slug to Update 2 from Update 3) By Jaiveer Shekhawat and Laura Matthews (Reuters) -Intercontinental Exchange reported third-quarter profit in line with expectations on Thursday, as strong trading volumes in the energy and options segments helped offset higher expenses for the New York Stock Exchange parent. Conflict in the Middle East and diverging views …
NYSE-parent ICE’s profit meets estimates as strong trading offsets higher expenses Read More »
By Kannaki Deka (Reuters) -Peloton Interactive has appointed former Apple executive Peter Stern its CEO and president effective Jan. 1, the company said on Thursday, to steer a turnaround following a post-pandemic demand slump, sending its shares up more than 24%. Stern, 52, is currently president of Ford Motor’s digital services business, responsible for a …
Peloton appoints former Apple executive Peter Stern as CEO to steer turnaround Read More »
By Manya Saini and Tatiana Bautzer (Reuters) -Investment bank Lazard reported a surge in third-quarter profit on Thursday, driven by an industry-wide recovery in dealmaking. After a dry spell lasting more than two years due to elevated interest rates and market volatility, corporate clients are now once again looking to pursue large multi-billion dollar deals …
Investment bank Lazard’s profit surges on dealmaking recovery Read More »
(Reuters) – Nikola reported a bigger-than-expected quarterly loss on Thursday as the company continues to grapple with high costs related to the production ramp up of its fuel-cell electric truck, sending the EV maker’s shares down more than 5%. The company’s wholesale deliveries of hydrogen-powered electric trucks jumped 22% in the third quarter from the …
EV maker Nikola posts bigger-than-expected quarterly loss, shares fall Read More »
